Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
31.00
+0.75 (2.48%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Arcus Biosciences Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Arcus Biosciences stock have an average target of 36.2, with a low estimate of 22 and a high estimate of 47. The average target predicts an increase of 16.77% from the current stock price of 31.00.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Arcus Biosciences stock from 13 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 10 | 9 | 9 | 9 | 9 | 10 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Unknown Analyst Mizuho Securities No rating | Mizuho Securities | Buy Maintains $47 | Buy | Maintains | $47 | +51.61% | Jun 10, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | Jun 4, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Initiates $46 | Buy | Initiates | $46 | +48.39% | Jun 4, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $32 | Buy | Maintains | $32 | +3.23% | Jun 3, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $20 → $22 | Hold | Maintains | $20 → $22 | -29.03% | May 11, 2026 |
Financial Forecast
Revenue This Year
85.06M
from 247.00M
Decreased by -65.56%
Revenue Next Year
93.06M
from 85.06M
Increased by 9.40%
EPS This Year
-3.48
from -3.29
EPS Next Year
-3.10
from -3.48
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 152.0M | 354.5M | |
| Avg | 85.1M | 93.1M | |
| Low | 53.4M | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -38.5% | 316.7% | |
| Avg | -65.6% | 9.4% | |
| Low | -78.4% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.63 | -1.55 | |
| Avg | -3.48 | -3.10 | |
| Low | -4.88 | -4.55 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.